S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
Critical asset just had biggest fall on record (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
Critical asset just had biggest fall on record (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
Critical asset just had biggest fall on record (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
Critical asset just had biggest fall on record (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case

Lumos Pharma (LUMO) Short Interest Ratio & Short Volume

$3.00
-0.05 (-1.64%)
(As of 03/1/2024 ET)

Lumos Pharma Short Interest Data

Current Short Volume
297,200 shares
Previous Short Volume
290,100 shares
Change Vs. Previous Month
+2.45%
Dollar Volume Sold Short
$906,460.00
Short Interest Ratio / Days to Cover
12.6
Last Record Date
February 15, 2024
Outstanding Shares
7,910,000 shares
Float Size
4,740,000 shares
Short Percent of Float
6.27%
Today's Trading Volume
11,403 shares
Average Trading Volume
19,566 shares
Today's Volume Vs. Average
58%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Lumos Pharma ?

Sign up to receive the latest short interest report for Lumos Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LUMO Short Interest Over Time

LUMO Days to Cover Over Time

LUMO Percentage of Float Shorted Over Time


Lumos Pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/2024297,200 shares $906,460.00 +2.5%6.3%12.6 $3.05
1/31/2024290,100 shares $818,082.00 +4.9%6.2%2.2 $2.82
1/15/2024276,600 shares $824,268.00 -3.6%5.9%2.1 $2.98
12/31/2023286,900 shares $912,342.00 -0.9%6.1%2.2 $3.18
12/15/2023289,600 shares $825,360.00 -6.7%6.2%2.2 $2.85
11/30/2023310,500 shares $888,030.00 -29.3%6.6%2.4 $2.86
11/15/2023439,200 shares $1.35 million +82.4%9.5%3.4 $3.08
10/31/2023240,800 shares $886,144.00 -6.8%5.2%2.1 $3.68
10/15/2023258,300 shares $1.07 million +11.6%5.6%14.7 $4.16
9/30/2023231,400 shares $763,620.00 -1.4%5.0%12.5 $3.30
9/15/2023234,700 shares $760,428.00 +10.1%5.1%12.3 $3.24
8/31/2023213,200 shares $594,828.00 +3.3%4.5%9.9 $2.79
8/15/2023206,300 shares $608,585.00 +12.6%4.4%8.1 $2.95
7/31/2023183,300 shares $619,554.00 -0.5%3.8%7.3 $3.38
7/15/2023184,300 shares $593,446.00 +3.5%3.8%7.7 $3.22
6/30/2023178,000 shares $587,400.00 +2.2%3.7%8 $3.30
6/15/2023174,200 shares $644,540.00 +0.2%3.6%9.2 $3.70
5/31/2023173,800 shares $637,846.00 +3.2%3.6%10.7 $3.67
5/15/2023168,500 shares $539,200.00 +1.3%3.7%13.6 $3.20
4/30/2023166,400 shares $500,864.00 -2.6%3.7%12.7 $3.01
4/15/2023170,800 shares $577,304.00 -1.6%3.8%12.9 $3.38
3/31/2023173,500 shares $574,285.00 -0.3%3.8%12.4 $3.31
3/15/2023174,100 shares $597,163.00 +0.3%3.8%9.2 $3.43
2/28/2023173,600 shares $597,184.00 +3.0%3.9%7.4 $3.44
2/15/2023168,600 shares $554,694.00 +2.0%3.7%7.4 $3.29
1/31/2023165,300 shares $578,550.00 -27.4%3.5%5.4 $3.50
1/15/2023227,600 shares $910,400.00 -0.7%4.6%8.2 $4.00
12/30/2022229,100 shares $827,051.00 +0.2%4.6%8.4 $3.61
12/15/2022228,600 shares $754,380.00 -0.1%4.6%9 $3.30
11/30/2022228,900 shares $1.17 million +26.9%4.6%10.7 $5.12
11/15/2022180,400 shares $892,980.00 -12.4%3.6%9.9 $4.95
10/31/2022206,000 shares $1.86 million +4.1%4.2%22.6 $9.03
10/15/2022197,900 shares $1.78 million -18.7%4.0%19.2 $9.00
9/30/2022243,500 shares $2.15 million -2.4%5.0%22.8 $8.85
9/15/2022249,600 shares $2.11 million +37.2%5.1%28 $8.47
8/31/2022181,900 shares $1.54 million -0.7%3.7%20.2 $8.47
8/15/2022183,100 shares $1.59 million +0.7%3.7%19.9 $8.70
7/31/2022181,800 shares $1.50 million -40.8%3.8%17.5 $8.26
7/15/2022307,100 shares $2.35 million +1,706.5%6.4%29.8 $7.67
6/30/202217,000 shares $130,900.00 No Change0.4%1.4 $7.70













LUMO Short Interest - Frequently Asked Questions

What is Lumos Pharma's current short interest?

Short interest is the volume of Lumos Pharma shares that have been sold short but have not yet been covered or closed out. As of February 15th, investors have sold 297,200 shares of LUMO short. 6.27% of Lumos Pharma's shares are currently sold short. Learn More on Lumos Pharma's current short interest.

What is a good short interest ratio for Lumos Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LUMO shares currently have a short interest ratio of 13.0. Learn More on Lumos Pharma's short interest ratio.

Which institutional investors are shorting Lumos Pharma?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Lumos Pharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Lumos Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.27% of Lumos Pharma's floating shares are currently sold short.

Is Lumos Pharma's short interest increasing or decreasing?

Lumos Pharma saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 297,200 shares, an increase of 2.4% from the previous total of 290,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Lumos Pharma's float size?

Lumos Pharma currently has issued a total of 7,910,000 shares. Some of Lumos Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lumos Pharma currently has a public float of 4,740,000 shares.

How does Lumos Pharma's short interest compare to its competitors?

6.27% of Lumos Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Lumos Pharma: CalciMedica, Inc. (0.49%), NeuroSense Therapeutics Ltd. (1.63%), Kineta, Inc. (0.35%), NeuroBo Pharmaceuticals, Inc. (4.12%), TherapeuticsMD, Inc. (0.50%), Talphera, Inc. (0.57%), NRx Pharmaceuticals, Inc. (6.82%), Lexaria Bioscience Corp. (6.61%), CytoMed Therapeutics Limited (0.58%), Aileron Therapeutics, Inc. (0.78%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Lumos Pharma stock?

Short selling LUMO is an investing strategy that aims to generate trading profit from Lumos Pharma as its price is falling. LUMO shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Lumos Pharma?

A short squeeze for Lumos Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LUMO, which in turn drives the price of the stock up even further.

How often is Lumos Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LUMO, twice per month. The most recent reporting period available is February, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:LUMO) was last updated on 3/3/2024 by MarketBeat.com Staff